Why no further research on CrPic in AD?
QUESTION:
Hi Doctor,
I read several articles related to the Duke University research on Chromax® chromium picolinate. I was excited at beginning and then disappointed when I could not find any further research on the subject. I looked through your site and failed to see proofs of patients that can testify sustained recovery or relief. Then I found Nutrition 21, the company makes Chromax is in deep red financially. Can you please tell me if Chromax can achieve sustained benefit to atypical depression? Why there are no extensive reports on these lately?
Thanks,
CF
ANSWER
There has been a further study on chromium picolinate in atypical depression. The conclusions reached from the study were that in adults with atypical depression, 600 micrograms per day of Chromax chromium picolinate helped control appetite and excessive eating, it reduced carbohydrate craving, and it "smoothed out" diurnal variation of feelings (daily mood fluctuations). In those patients with high carbohydrate craving, chromium picoliante improved overall HAM-D-29 depression scores.
Several of my patients have taken chromium picolinate for a decade and have been depression free.
I wish there were a study in which depressed patients with carbohydrate craving and increased appetite were given chromium picolinate. Will this happen? I'm afraid not. It's a matter of money. Because chromium picolinate is readily available and is inexpensive, pharma companies are not interested in supporting such research.
Thank you so much for your question.
MM

